Drugs · acquisition-cost intelligence
Antifungal
antifungal· ingredient clotrimazoleAntiinfectives and antiseptics for local oral treatment· CLOTRIMAZOLE .01 g/g; CLOTRIMAZOLE 10 mg/g; CLOTRIMAZOLE 10 mg/mL; CLOTRIMAZOLE 1 g/100g
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per GM
$0.13045
NADAC — pharmacy acquisition cost, not a retail/cash price
Acquisition-cost history
Weekly NADAC per GM — the trend nobody else shows. 7 weeks.
2025-03-192026-05-20
Same-ingredient options by acquisition cost
Other clotrimazole products, cheapest acquisition cost first. Per GM — confirm strength/form equivalence before switching.
| Product | NADAC / GM | vs this |
|---|---|---|
| Femmesil | $0.08864 | −$0.04180 |
| clotrimazole | $0.28713 | +$0.15670 |
| CVS Pharmacy Clotrimazole 3 | $0.30100 | +$0.17060 |
| AKIN ANTI-FUNGAL | $0.51121 | +$0.38080 |
Medicare Part D coverage · CY2026
On 328 plan formularies · typical tier 2
Prior auth 0% · Step therapy 0% · Quantity limit 51% of formularies
Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.